Tirzepatide

CAS Number: 2023788-19-2
Molecular Formula: C₂₂₅H₃₄₈N₄₈O₆₈
Molecular Weight: 4813.49 g/mol
Sequence: A synthetic linear peptide of 39 amino acids, modified with C20 fatty diacid for albumin binding and half-life extension

___________________________

Tirzepatide is a novel dual agonist of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. Structurally engineered to enhance pharmacokinetic stability, Tirzepatide combines selective receptor activity with a prolonged half-life via fatty acid modification, allowing for once-weekly dosing in clinical applications.

____________________________

Tirzepatide is under active investigation for its multi-pathway metabolic impact, with particular relevance in:

Glucose Regulation: Studying potentiation of insulin secretion, inhibition of glucagon, and modulation of postprandial glucose levels.

Obesity and Weight Loss: Evaluating dual receptor activation effects on appetite suppression, energy expenditure, and body composition.

Cardiometabolic Research: Exploring impact on lipid profiles, blood pressure, and inflammatory markers.

Beta Cell Function: Investigating preservation and enhancement of pancreatic beta-cell activity in diabetes models.

______________________________

For Research Use Only

Tirzepatide offered by PeptideStock.com is intended strictly for in vitro and in vivo research by qualified professionals. It is not for human consumption, therapeutic use, or clinical administration. Please follow all standard lab safety procedures during handling and storage.